HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin W Brechbiel Selected Research

N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acid

4/2008A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules.
7/2003Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin W Brechbiel Research Topics

Disease

104Neoplasms (Cancer)
05/2020 - 01/2002
8Peritoneal Diseases
10/2017 - 12/2004
8Lymphoma (Lymphomas)
06/2009 - 02/2003
6Breast Neoplasms (Breast Cancer)
05/2015 - 06/2003
6Leukemia
05/2007 - 02/2003
5Ovarian Neoplasms (Ovarian Cancer)
10/2017 - 09/2004
5Colorectal Neoplasms (Colorectal Cancer)
08/2015 - 07/2010
4Neoplasm Micrometastasis
10/2016 - 08/2002
4Carcinoma (Carcinomatosis)
06/2010 - 12/2003
4Acute Kidney Injury (Acute Renal Failure)
01/2006 - 04/2004
3Melanoma (Melanoma, Malignant)
01/2015 - 07/2008
3Mesothelioma
04/2013 - 07/2005
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2006 - 07/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
11/2005 - 10/2002
3Glioma (Gliomas)
10/2004 - 10/2002
2Hodgkin Disease (Hodgkin's Disease)
05/2020 - 10/2015
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2020 - 10/2015
2Prostatic Neoplasms (Prostate Cancer)
10/2016 - 01/2009
2Malignant Mesothelioma
04/2013 - 03/2011
2Colonic Neoplasms (Colon Cancer)
03/2013 - 03/2012
2Neoplasm Metastasis (Metastasis)
01/2012 - 06/2007
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2006 - 08/2006
2T-Cell Leukemia (Leukemia, T Cell)
08/2006 - 04/2004
2Lymphatic Metastasis
04/2006 - 05/2004
2Ischemia
01/2006 - 06/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
02/2004 - 10/2003

Drug/Important Bio-Agent (IBA)

33Monoclonal AntibodiesIBA
10/2015 - 05/2002
19Radioisotopes (Radionuclides)IBA
10/2017 - 04/2002
15AntibodiesIBA
12/2016 - 02/2004
15Trastuzumab (Herceptin)FDA Link
01/2015 - 02/2002
13Contrast MediaIBA
01/2015 - 01/2002
11Immunoconjugates (Immunoconjugate)IBA
02/2011 - 05/2002
11Chelating AgentsIBA
05/2009 - 04/2002
9AntigensIBA
05/2020 - 02/2002
9Dendrimers (Dendrons)IBA
11/2012 - 09/2003
8GadoliniumIBA
11/2012 - 01/2003
8tachpyrIBA
12/2005 - 07/2002
6Panitumumab (Vectibix)FDA Link
06/2018 - 06/2010
6Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 04/2006
6MetalsIBA
05/2014 - 07/2002
6Pharmaceutical PreparationsIBA
11/2005 - 10/2002
6IronIBA
11/2005 - 07/2002
5GemcitabineFDA Link
06/2018 - 03/2007
5LigandsIBA
07/2013 - 03/2007
5ErbB Receptors (EGF Receptor)IBA
04/2013 - 10/2005
5AvidinIBA
09/2007 - 01/2003
5IsotopesIBA
08/2007 - 08/2002
4Immunoglobulin G (IgG)IBA
06/2018 - 04/2002
4Single-Chain AntibodiesIBA
08/2008 - 02/2003
4StreptavidinIBA
01/2008 - 07/2002
3Daclizumab (Zenapax)FDA Link
05/2020 - 07/2006
3IntegrinsIBA
05/2015 - 09/2012
3Peptides (Polypeptides)IBA
09/2011 - 04/2008
3AcidsIBA
06/2010 - 07/2002
3N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
05/2009 - 09/2004
3Hu3S193 monoclonal antibodyIBA
01/2009 - 04/2006
3Therapeutic UsesIBA
02/2008 - 09/2003
3Biotin (Vitamin H)FDA Link
09/2007 - 02/2003
3PolyaminesIBA
01/2006 - 09/2004
3DOTA-biotin (90Y-DOTA-biotin)IBA
07/2005 - 07/2002
2Neoplasm Antigens (Tumor Antigens)IBA
06/2016 - 06/2004
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2015 - 11/2013
2tigatuzumabIBA
08/2015 - 11/2013
2Cetuximab (Erbitux)FDA Link
01/2015 - 07/2010
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2015 - 09/2012
2Biomarkers (Surrogate Marker)IBA
02/2011 - 06/2005
2Pentetic Acid (DTPA)FDA LinkGeneric
06/2010 - 08/2008
2Biological ProductsIBA
06/2010 - 06/2007
2Glycoproteins (Glycoprotein)IBA
02/2010 - 07/2005
2tumor-associated antigen 72IBA
02/2010 - 10/2005
2Lewis Y antigenIBA
11/2009 - 06/2007
2CalicheamicinsIBA
11/2009 - 04/2004
2Yttrium-90IBA
06/2009 - 09/2004
2N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
04/2008 - 07/2003
2thiol-maleimideIBA
04/2008 - 09/2007
2Astatine-211IBA
02/2008 - 08/2006
2Indium-111IBA
06/2007 - 09/2003
2Interleukin-2 Receptor alpha SubunitIBA
08/2006 - 07/2002
2Fc Receptors (Fc Receptor)IBA
07/2006 - 08/2004
2Proteins (Proteins, Gene)FDA Link
07/2005 - 02/2003
2Anti-Bacterial Agents (Antibiotics)IBA
06/2005 - 04/2004
2BismuthIBA
05/2004 - 07/2002
1Etoposide (VP 16)FDA LinkGeneric
05/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2020
1Carmustine (FIVB)FDA Link
05/2020
1Melphalan (Alkeran)FDA LinkGeneric
05/2020
1RadiopharmaceuticalsIBA
01/2018
1Dihydrotachysterol (AT 10)IBA
08/2017
1Urea (Carbamide)FDA LinkGeneric
10/2016
1LuciferasesIBA
10/2016
1epacadostatIBA
06/2016
1Immunoglobulins (Immunoglobulin)IBA
08/2015

Therapy/Procedure

46Therapeutics
05/2020 - 04/2002
34Radioimmunotherapy
12/2016 - 04/2002
13Radiotherapy
10/2017 - 02/2003
4Drug Therapy (Chemotherapy)
05/2020 - 04/2006
3Neutron Capture Therapy
12/2005 - 01/2003
2Injections
06/2018 - 08/2006
2Immunotherapy
08/2002 - 07/2002
1Biological Therapy
01/2018